Immunotherapy for kidney cancer—also called renal cell carcinoma—has tremendously changed the treatment landscape and overall survival of patients with metastatic kidney cancer. The Cancer Research Institute has supported the best scientists in the field working toward the improvement of kidney cancer treatment from basic laboratory work on interferon to clinical trials testing new therapies.
Monthly donations help us plan and allocate resources effectively to advance research and save more lives.
Create a card as part of my donation.
I want to receive the latest immunotherapy news
Find out if your employer will match your donation:
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
By clicking I agree to the terms & conditions
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442.Donations are tax-deductible to the fullest extent allowable under the law.